Lycopodium Limited (ASX:LYL)
Australia · Delayed Price · Currency is AUD 22.92
+0.68 (3.06%)
Aug 31, 2026, 4:10 PM AEST
Lycopodium Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 374.02 | 333.94 | 344.55 | 323.88 | 228.71 |
| 374.02 | 333.94 | 344.55 | 323.88 | 228.71 | |
Revenue Growth | 12.00% | -3.08% | 6.38% | 41.61% | 44.70% |
Cost of Revenue | 295.18 | 242.08 | 258.03 | 237.17 | 180.71 |
Gross Profit | 78.84 | 91.86 | 86.52 | 86.71 | 48 |
Selling, General & Admin | 3.13 | 3.36 | 2.35 | 2.15 | 1.76 |
Other Operating Expenses | 23.93 | 26.39 | 21.45 | 14.04 | 12.8 |
Operating Expenses | 34.79 | 36.7 | 30.38 | 22.55 | 20.19 |
Operating Income | 44.05 | 55.16 | 56.14 | 64.16 | 27.81 |
Interest Expense | -1.07 | -1.2 | -0.76 | -0.84 | -0.89 |
Interest & Investment Income | 1.76 | 2.43 | 3.43 | 1.65 | 0.56 |
Earnings From Equity Investments | 5.2 | 2.9 | 2.51 | 2.06 | -0.2 |
Other Non Operating Income (Expenses) | 2.32 | 1.22 | 8.41 | -3.76 | 11.2 |
EBT Excluding Unusual Items | 52.26 | 60.51 | 69.74 | 63.28 | 38.49 |
Gain (Loss) on Sale of Investments | 0.2 | - | - | - | 0.44 |
Pretax Income | 52.46 | 60.51 | 69.74 | 63.28 | 38.93 |
Income Tax Expense | 11.9 | 18.03 | 18.8 | 17.72 | 12.07 |
Earnings From Continuing Operations | 40.56 | 42.48 | 50.93 | 45.56 | 26.85 |
Minority Interest in Earnings | -0.39 | -0.26 | -0.22 | 1.22 | 0.33 |
Net Income | 40.17 | 42.22 | 50.71 | 46.78 | 27.18 |
Net Income to Common | 40.17 | 42.22 | 50.71 | 46.78 | 27.18 |
Net Income Growth | -4.85% | -16.75% | 8.41% | 72.13% | 91.40% |
Shares Outstanding (Basic) | 40 | 40 | 40 | 40 | 40 |
Shares Outstanding (Diluted) | 40 | 40 | 40 | 40 | 40 |
Shares Change | - | - | - | - | -0.69% |
EPS (Basic) | 1.01 | 1.06 | 1.28 | 1.18 | 0.68 |
EPS (Diluted) | 1.01 | 1.06 | 1.28 | 1.18 | 0.68 |
EPS Growth | -4.82% | -16.78% | 8.40% | 72.13% | 92.64% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 56.89 | 35.26 | 24.46 | 14.42 | 36.83 |
Free Cash Flow Per Share | 1.43 | 0.89 | 0.62 | 0.36 | 0.93 |
Dividend Per Share | 0.590 | 0.350 | 0.770 | 0.810 | 0.540 |
Dividend Growth | 68.57% | -54.55% | -4.94% | 50.00% | 116.00% |
Gross Margin | 21.08% | 27.51% | 25.11% | 26.77% | 20.99% |
Operating Margin | 11.78% | 16.52% | 16.29% | 19.81% | 12.16% |
Profit Margin | 10.74% | 12.64% | 14.72% | 14.44% | 11.88% |
Free Cash Flow Margin | 15.21% | 10.56% | 7.10% | 4.45% | 16.10% |
EBITDA | 47.19 | 57.95 | 58.68 | 66.52 | 29.53 |
EBITDA Margin | 12.62% | 17.35% | 17.03% | 20.54% | 12.91% |
D&A For EBITDA | 3.14 | 2.79 | 2.54 | 2.36 | 1.72 |
EBIT | 44.05 | 55.16 | 56.14 | 64.16 | 27.81 |
EBIT Margin | 11.78% | 16.52% | 16.29% | 19.81% | 12.16% |
Effective Tax Rate | 22.68% | 29.79% | 26.96% | 28.00% | 31.02% |
Revenue as Reported | 377.55 | 339.61 | 348.88 | 327.57 | 232.16 |